Literature DB >> 17855802

Sex specifically associated promoter polymorphism in multiple sclerosis affects interleukin 4 expression levels.

D A Akkad1, L Arning, S M Ibrahim, J T Epplen.   

Abstract

The interleukin 4 promoter polymorphism -589 C/T (rs2243250) was genotyped in 869 multiple sclerosis (MS) patients and 595 healthy blood donors. Sex-specific MS association was evident whereas two flanking polymorphisms showed insignificant P values. In dual luciferase assays of cultured Jurkat cells the cloned promoter comprising the -589 T allele leads to higher expression as compared to the respective construct with the C allele. Together these findings may be discussed functionally as contributing to the genetic predisposition and to the pathogenesis in MS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17855802     DOI: 10.1038/sj.gene.6364429

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  8 in total

1.  Association between interleukin-4 and interleukin-10 single nucleotide polymorphisms and multiple sclerosis among Iraqi patients.

Authors:  Milad A Al-Naseri; Ehab D Salman; Ali H Ad'hiah
Journal:  Neurol Sci       Date:  2019-07-01       Impact factor: 3.307

2.  Clinical relevance of 13 cytokine gene polymorphisms in Chinese major trauma patients.

Authors:  Wei Gu; Ling Zeng; Jian Zhou; Dong-po Jiang; Lianyang Zhang; Ding-yuan Du; Ping Hu; Kehong Chen; Qin Liu; Zheng-guo Wang; Jian-xin Jiang
Journal:  Intensive Care Med       Date:  2010-03-09       Impact factor: 17.440

3.  Family Analysis of Linkage and Association of HLA-DRB1, CTLA4, TGFB1, IL4, CCR5, RANTES, MMP9 and TIMP1 Gene Polymorphisms with Multiple Sclerosis.

Authors:  O Yu Makarycheva; E Yu Tsareva; M A Sudomoina; O G Kulakova; B V Titov; O V Bykova; N V Gol'tsova; L M Kuzenkova; A N Boiko; O O Favorova
Journal:  Acta Naturae       Date:  2011-01       Impact factor: 1.845

4.  Variants of Mitochondrial Genome and Risk of Multiple Sclerosis Development in Russians.

Authors:  M S Kozin; O G Kulakova; I S Kiselev; O P Balanovsky; A N Boyko; O O Favorova
Journal:  Acta Naturae       Date:  2018 Oct-Dec       Impact factor: 1.845

5.  IL-4 polymorphism influences susceptibility to Pneumocystis jirovecii pneumonia in HIV-positive patients.

Authors:  Agnieszka Wójtowicz; Stéphanie Bibert; Patrick Taffé; Enos Bernasconi; Hansjakob Furrer; Huldrych F Günthard; Matthias Hoffmann; Michael Osthoff; Matthias Cavassini; Pierre-Yves Bochud
Journal:  AIDS       Date:  2019-09-01       Impact factor: 4.177

Review 6.  Increased susceptibility to pneumonia due to tumour necrosis factor inhibition and prospective immune system rescue via immunotherapy.

Authors:  Ryan Ha; Yoav Keynan; Zulma Vanessa Rueda
Journal:  Front Cell Infect Microbiol       Date:  2022-09-07       Impact factor: 6.073

Review 7.  Pleiotropic Effects of Immune Responses Explain Variation in the Prevalence of Fibroproliferative Diseases.

Authors:  Shirley B Russell; Joan C Smith; Minjun Huang; Joel S Trupin; Scott M Williams
Journal:  PLoS Genet       Date:  2015-11-05       Impact factor: 5.917

8.  Interleukin 4 gene polymorphism (-589C/T) and the risk of asthma: a meta-analysis and met-regression based on 55 studies.

Authors:  Ahmad Kousha; Armita Mahdavi Gorabi; Mehdi Forouzesh; Mojgan Hosseini; Markov Alexander; Danyal Imani; Bahman Razi; Mohammad Javad Mousavi; Saeed Aslani; Haleh Mikaeili
Journal:  BMC Immunol       Date:  2020-10-21       Impact factor: 3.615

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.